Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas

Clinical article

Shigeo Ohba M.D., Ph.D. 1 , Masahito Kobayashi M.D., Ph.D. 2 , Takashi Horiguchi M.D., Ph.D. 1 , Satoshi Onozuka M.D. 1 , Kazunari Yoshida M.D., Ph.D. 1 , Takayuki Ohira M.D., Ph.D. 1 , and Takeshi Kawase M.D., Ph.D. 1
View More View Less
  • 1 Department of Neurosurgery, Keio University School of Medicine, Tokyo; and
  • 2 Department of Neurosurgery, Saitama Medical University, Saitama, Japan
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

Although gross-total resection (GTR) is a preferable treatment for skull base meningiomas, subtotal resection (STR) with or without radiation therapy can be considered as an alternative treatment for patients at considerable surgical risk. The long-term prognosis of such patients might be related to the biological activity of the tumor. This study examined predictors of progression-free survival (PFS) and sought to determine the optimal treatment strategies, focusing on the pathobiological findings of skull base meningiomas.

Methods

This study included 281 patients with skull base meningiomas (mean follow-up period 88.4 months). Risk factors for tumor progression were examined using a multivariate analysis. The PFS and overall survival (OS) rates were evaluated using the Kaplan-Meier method. The functional outcomes of the patients were measured using the Karnofsky Performance Scale (KPS).

Results

The 10-year PFS and OS rates were 66.4% and 97.4%, respectively. Overall, 83.3% of patients achieved a favorable outcome, that is, an improved or unchanged KPS score. The extent of resection, additional radiotherapy, histological grade, MIB-1 index, and p53-positive rate were significantly associated with PFS. The PFS of patients undergoing STR without radiation therapy was significantly shorter than that of either those undergoing STR with radiation therapy or GTR, while no statistical difference was observed between the latter 2 groups. Among the patients undergoing STR with pathobiological risk factors (histological grade, MIB-1 index, and p53-positive rate), the PFS of the patients who received radiation therapy was better than that of those who did not receive radiation therapy. Among the patients undergoing STR without such risk factors, the PFS was not significantly different between patients who received radiation therapy and those who did not.

Conclusions

For patients with skull base meningiomas, a GTR is desirable and additional radiation therapy after STR may contribute to a longer PFS. Additional radiation therapy should be recommended, especially for patients with pathobiological risk factors, but not necessarily for those without such risks.

Abbreviations used in this paper: CPA = cerebellopontine angle; GTR = gross-total resection; KPS = Karnofsky Performance Scale; OS = overall survival; PFS = progression-free survival; PR = partial resection; STR = subtotal resection.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Shigeo Ohba, M.D., Ph.D., Department of Neurosurgery, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo 160-8582, Japan. email: shigeo.ohba@gmail.com.

Please include this information when citing this paper: published online December 17, 2010; DOI: 10.3171/2010.11.JNS10701.

  • 1

    Adachi K, , Kawase T, , Yoshida K, , Yazaki T, & Onozuka S: ABC Surgical Risk Scale for skull base meningioma: a new scoring system for predicting the extent of tumor removal and neurological outcome. Clinical article. J Neurosurg 111:10531061, 2009

    • Search Google Scholar
    • Export Citation
  • 2

    Aichholzer M, , Bertalanffy A, , Dietrich W, , Roessler K, , Pfisterer W, & Ungersboeck K, : Gamma knife radiosurgery of skull base meningiomas. Acta Neurochir (Wien) 142:647653, 2000

    • Search Google Scholar
    • Export Citation
  • 3

    Al-Mefty O, , Kadri PA, , Pravdenkova S, , Sawyer JR, , Stangeby C, & Husain M: Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210218, 2004

    • Search Google Scholar
    • Export Citation
  • 4

    Amatya VJ, , Takeshima Y, & Inai K: Methylation of p14(ARF) gene in meningiomas and its correlation to the p53 expression and mutation. Mod Pathol 17:705710, 2004

    • Search Google Scholar
    • Export Citation
  • 5

    Arai H, , Beppu T, , Wada T, , Yoshida Y, , Kubo Y, & Suzuki M, : Pathological analyses of early recurrence and malignant transformation in meningiomas. Brain Tumor Pathol 15:3740, 1998

    • Search Google Scholar
    • Export Citation
  • 6

    Ayerbe J, , Lobato RD, , de la Cruz J, , Alday R, , Rivas JJ, & Gómez PA, : Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir (Wien) 141:921932, 1999

    • Search Google Scholar
    • Export Citation
  • 7

    Bambakidis NC, , Kakarla UK, , Kim LJ, , Nakaji P, , Porter RW, & Daspit CP, : Evolution of surgical approaches in the treatment of petroclival meningiomas: a retrospective review. Neurosurgery 61:5 Suppl 2 202211, 2007

    • Search Google Scholar
    • Export Citation
  • 8

    Bondy M, & Ligon BL: Epidemiology and etiology of intracranial meningiomas: a review. J Neurooncol 29:197205, 1996

  • 9

    Couldwell WT, , Fukushima T, , Giannotta SL, & Weiss MH: Petroclival meningiomas: surgical experience in 109 cases. J Neurosurg 84:2028, 1996

    • Search Google Scholar
    • Export Citation
  • 10

    Dufour H, , Muracciole X, , Métellus P, , Régis J, , Chinot O, & Grisoli F: Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal?. Neurosurgery 48:285296, 2001

    • Search Google Scholar
    • Export Citation
  • 11

    Ellison DW, , Lunec J, , Gallagher PJ, , Steart PV, , Jaros E, & Gatter KC: Accumulation of wild-type p53 in meningiomas. Neuropathol Appl Neurobiol 21:136142, 1995

    • Search Google Scholar
    • Export Citation
  • 12

    Gerdes J, , Lemke H, , Baisch H, , Wacker HH, , Schwab U, & Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:17101715, 1984

    • Search Google Scholar
    • Export Citation
  • 13

    Gerdes J, , Li L, , Schlueter C, , Duchrow M, , Wohlenberg C, & Gerlach C, : Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867873, 1991

    • Search Google Scholar
    • Export Citation
  • 14

    Hahn BM, , Schrell UM, , Sauer R, , Fahlbusch R, , Ganslandt O, & Grabenbauer GG: Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study. J Neurooncol 74:157165, 2005

    • Search Google Scholar
    • Export Citation
  • 15

    Ho DM, , Hsu CY, , Ting LT, & Chiang H: Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 94:15381547, 2002

    • Search Google Scholar
    • Export Citation
  • 16

    Ildan F, , Erman T, , Göçer AI, , Tuna M, , Bağdatoğlu H, & Cetinalp E, : Predicting the probability of meningioma recurrence in the preoperative and early postoperative period: a multivariate analysis in the midterm follow-up. Skull Base 17:157171, 2007

    • Search Google Scholar
    • Export Citation
  • 17

    Iwai Y, , Yamanaka K, & Ishiguro T: Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 52:517524, 2003

    • Search Google Scholar
    • Export Citation
  • 18

    Johnson MD, , Sade B, , Milano MT, , Lee JH, & Toms SA: New prospects for management and treatment of inoperable and recurrent skull base meningiomas. J Neurooncol 86:109122, 2008

    • Search Google Scholar
    • Export Citation
  • 19

    Kim YJ, , Ketter R, , Henn W, , Zang KD, , Steudel WI, & Feiden W: Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 449:529538, 2006

    • Search Google Scholar
    • Export Citation
  • 20

    Konstantinidou AE, , Pavlopoulos PM, , Patsouris E, , Kaklamanis L, & Davaris P: Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186:325330, 1998

    • Search Google Scholar
    • Export Citation
  • 21

    Korshunov A, , Shishkina L, & Golanov A: Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome. Int J Cancer 104:728734, 2003

    • Search Google Scholar
    • Export Citation
  • 22

    Lamszus K, , Kluwe L, , Matschke J, , Meissner H, , Laas R, & Westphal M: Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas. Cancer Genet Cytogenet 110:103110, 1999

    • Search Google Scholar
    • Export Citation
  • 23

    Lee JY, , Niranjan A, , McInerney J, , Kondziolka D, , Flickinger JC, & Lunsford LD: Stereotactic radiosurgery providing longterm tumor control of cavernous sinus meningiomas. J Neurosurg 97:6572, 2002

    • Search Google Scholar
    • Export Citation
  • 24

    Leonetti JP, , Anderson DE, , Marzo SJ, , Origitano TC, & Schuman R: Combined transtemporal access for large (>3 cm) meningiomas of the cerebellopontine angle. Otolaryngol Head Neck Surg 134:949952, 2006

    • Search Google Scholar
    • Export Citation
  • 25

    Li X, , Liu M, , Liu Y, & Zhu S: Surgical management of Tuberculum sellae meningiomas. J Clin Neurosci 14:11501154, 2007

  • 26

    Little KM, , Friedman AH, , Sampson JH, , Wanibuchi M, & Fukushima T: Surgical management of petroclival meningiomas: defining resection goals based on risk of neurological morbidity and tumor recurrence rates in 137 patients. Neurosurgery 56:546559, 2005

    • Search Google Scholar
    • Export Citation
  • 27

    Lunsford LD: Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?. J Neurosurg 80:187190, 1994

    • Search Google Scholar
    • Export Citation
  • 28

    Maier H, , Ofner D, , Hittmair A, , Kitz K, & Budka H: Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77:616623, 1992

    • Search Google Scholar
    • Export Citation
  • 29

    Maiuri F, , De Caro Mdel B, , Esposito F, , Cappabianca P, , Strazzullo V, & Pettinato G, : Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 82:6368, 2007

    • Search Google Scholar
    • Export Citation
  • 30

    Mathiesen T, , Lindquist C, , Kihlström L, & Karlsson B: Recurrence of cranial base meningiomas. Neurosurgery 39:29, 1996

  • 31

    Matsuno A, , Fujimaki T, , Sasaki T, , Nagashima T, , Ide T, & Asai A, : Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504510, 1996

    • Search Google Scholar
    • Export Citation
  • 32

    Matsuno A, , Nagashima T, , Matsuura R, , Tanaka H, , Hirakawa M, & Murakami M, : Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106:776781, 1996

    • Search Google Scholar
    • Export Citation
  • 33

    McCarthy BJ, , Davis FG, , Freels S, , Surawicz TS, , Damek DM, & Grutsch J, : Factors associated with survival in patients with meningioma. J Neurosurg 88:831839, 1998

    • Search Google Scholar
    • Export Citation
  • 34

    Metellus P, , Regis J, , Muracciole X, , Fuentes S, , Dufour H, & Nanni I, : Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery 57:873886, 2005

    • Search Google Scholar
    • Export Citation
  • 35

    Morita A, , Coffey RJ, , Foote RL, , Schiff D, & Gorman D: Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg 90:4249, 1999

    • Search Google Scholar
    • Export Citation
  • 36

    Nagashima G, , Aoyagi M, , Yamamoto M, , Yamamoto S, , Wakimoto H, & Ohno K, : P53 overexpression and proliferative potential in malignant meningiomas. Acta Neurochir (Wien) 141:5361, 1999

    • Search Google Scholar
    • Export Citation
  • 37

    Nakamura M, , Roser F, , Jacobs C, , Vorkapic P, & Samii M: Medial sphenoid wing meningiomas: clinical outcome and recurrence rate. Neurosurgery 58:626639, 2006

    • Search Google Scholar
    • Export Citation
  • 38

    Nakamura M, , Roser F, , Struck M, , Vorkapic P, & Samii M: Tuberculum sellae meningiomas: clinical outcome considering different surgical approaches. Neurosurgery 59:10191029, 2006

    • Search Google Scholar
    • Export Citation
  • 39

    Nakasu S, , Fukami T, , Nakajima M, , Watanabe K, , Ichikawa M, & Matsuda M: Growth pattern changes of meningiomas: longterm analysis. Neurosurgery 56:946955, 2005

    • Search Google Scholar
    • Export Citation
  • 40

    Nakasu S, , Li DH, , Okabe H, , Nakajima M, & Matsuda M: Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25:472478, 2001

    • Search Google Scholar
    • Export Citation
  • 41

    Nakasu S, , Nakasu Y, , Nakajima M, , Matsuda M, & Handa J: Preoperative identification of meningiomas that are highly likely to recur. J Neurosurg 90:455462, 1999

    • Search Google Scholar
    • Export Citation
  • 42

    Pamir MN, , Belirgen M, , Ozduman K, , Kiliç T, & Ozek M: Anterior clinoidal meningiomas: analysis of 43 consecutive surgically treated cases. Acta Neurochir (Wien) 150:625636, 2008

    • Search Google Scholar
    • Export Citation
  • 43

    Park CK, , Jung HW, , Kim JE, , Paek SH, & Kim DG: The selection of the optimal therapeutic strategy for petroclival meningiomas. Surg Neurol 66:160166, 2006

    • Search Google Scholar
    • Export Citation
  • 44

    Park CK, , Jung HW, , Yang SY, , Seol HJ, , Paek SH, & Kim DG: Surgically treated tuberculum sellae and diaphragm sellae meningiomas: the importance of short-term visual outcome. Neurosurgery 59:238243, 2006

    • Search Google Scholar
    • Export Citation
  • 45

    Perry A, , Louis DN, , Scheithauer BW, , Budka H, & Von Deimling A, Meningiomas. Louis DN, , Ohgaki H, & Wiestler OD, : WHO Classification of Tumors of the Central Nervous System ed 4. Lyon, IARC, 2007. 164172

    • Search Google Scholar
    • Export Citation
  • 46

    Perry A, , Scheithauer BW, , Stafford SL, , Lohse CM, & Wollan PC: “Malignancy” in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:20462056, 1999

    • Search Google Scholar
    • Export Citation
  • 47

    Perry A, , Stafford SL, , Scheithauer BW, , Suman VJ, & Lohse CM: Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21:14551465, 1997

    • Search Google Scholar
    • Export Citation
  • 48

    Perry A, , Stafford SL, , Scheithauer BW, , Suman VJ, & Lohse CM: The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:22622269, 1998

    • Search Google Scholar
    • Export Citation
  • 49

    Puzzilli F, , Ruggeri A, , Mastronardi L, , Agrillo A, & Ferrante L: Anterior clinoidal meningiomas: report of a series of 33 patients operated on through the pterional approach. Neuro Oncol 1:188195, 1999

    • Search Google Scholar
    • Export Citation
  • 50

    Rezanko T, , Akkalp AK, , Tunakan M, & Sari AA: MIB-1 counting methods in meningiomas and agreement among pathologists. Anal Quant Cytol Histol 30:4752, 2008

    • Search Google Scholar
    • Export Citation
  • 51

    Rohringer M, , Sutherland GR, , Louw DF, & Sima AA: Incidence and clinicopathological features of meningioma. J Neurosurg 71:665672, 1989

  • 52

    Roser F, , Samii M, , Ostertag H, & Bellinzona M: The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:3744, 2004

    • Search Google Scholar
    • Export Citation
  • 53

    Saberi H, , Meybodi AT, & Rezai AS: Levine-Sekhar grading system for prediction of the extent of resection of cranial base meningiomas revisited: study of 124 cases. Neurosurg Rev 29:138144, 2006

    • Search Google Scholar
    • Export Citation
  • 54

    Sade B, , Chahlavi A, , Krishnaney A, , Nagel S, , Choi E, & Lee JH: World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery 61:11941198, 2007

    • Search Google Scholar
    • Export Citation
  • 55

    Sekhar LN, & Jannetta PJ: Cerebellopontine angle meningiomas. Microsurgical excision and follow-up results. J Neurosurg 60:500505, 1984

    • Search Google Scholar
    • Export Citation
  • 56

    Sekhar LN, , Swamy NK, , Jaiswal V, , Rubinstein E, , Hirsch WE Jr, & Wright DC: Surgical excision of meningiomas involving the clivus: preoperative and intraoperative features as predictors of postoperative functional deterioration. J Neurosurg 81:860868, 1994

    • Search Google Scholar
    • Export Citation
  • 57

    Shin M, , Kurita H, , Sasaki T, , Kawamoto S, , Tago M, & Kawahara N, : Analysis of treatment outcome after stereotactic radiosurgery for cavernous sinus meningiomas. J Neurosurg 95:435439, 2001

    • Search Google Scholar
    • Export Citation
  • 58

    Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:2239, 1957

  • 59

    Stafford SL, , Perry A, , Suman VJ, , Meyer FB, , Scheithauer BW, & Lohse CM, : Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936942, 1998

    • Search Google Scholar
    • Export Citation
  • 60

    Terzi A, , Saglam EA, , Barak A, & Soylemezoglu F: The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays. Pathol Res Pract 204:305314, 2008

    • Search Google Scholar
    • Export Citation
  • 61

    Voss NF, , Vrionis FD, , Heilman CB, & Robertson JH: Meningiomas of the cerebellopontine angle. Surg Neurol 53:439447, 2000

  • 62

    Wang JL, , Zhang ZJ, , Hartman M, , Smits A, , Westermark B, & Muhr C, : Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer 64:223228, 1995

    • Search Google Scholar
    • Export Citation
  • 63

    Yang SY, , Park CK, , Park SH, , Kim DG, , Chung YS, & Jung HW: Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. J Neurol Neurosurg Psychiatry 79:574580, 2008

    • Search Google Scholar
    • Export Citation
  • 64

    Zachenhofer I, , Wolfsberger S, , Aichholzer M, , Bertalanffy A, , Roessler K, & Kitz K, : Gamma-knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. Neurosurgery 58:2836, 2006

    • Search Google Scholar
    • Export Citation
  • 65

    Zentner J, , Meyer B, , Vieweg U, , Herberhold C, & Schramm J: Petroclival meningiomas: is radical resection always the best option?. J Neurol Neurosurg Psychiatry 62:341345, 1997

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 574 150 9
Full Text Views 208 11 1
PDF Downloads 98 8 2
EPUB Downloads 0 0 0